Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study.

Ann Hematol · 2026 · PMC13006466 · PMID 41866558

Europe PMC DOI

hedged sentence

0.2520

closest p · 5.0× alpha

0.2520

boldest claim

The sentences

a favorable trendP = 0.252not close (p > 0.1)

OS showed a favorable trend (HR 0.703, P = 0.252).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.